Heterocyclic derivatives as M3 muscarinic receptors

Details for Australian Patent Application No. 2008215924 (hide)

Owner Pulmagen Therapeutics (Synergy) Limited

Inventors Finch, Harry; Nadin, Alan John; Knight, Jamie David; Ray, Nicholas Charles; Avitabile, Barbara Giuseppina

Agent Freehills

Pub. Number AU-B-2008215924

PCT Pub. Number WO2008/099186

Priority 0722678.0 19.11.07 GB; 0702994.5 15.02.07 GB

Filing date 14 February 2008

Wipo publication date 21 August 2008

Acceptance publication date 21 April 2011

International Classifications

C07D 471/08 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/439 (2006.01) - the ring forming part of a bridged ring system, e.g. quinuclidine

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

Event Publications

6 August 2009 PCT application entered the National Phase

  PCT publication WO2008/099186 Priority application(s): WO2008/099186

21 April 2011 Application Accepted

  Published as AU-B-2008215924

26 May 2011 Alteration of Name

  The name of the applicant has been altered to Pulmagen Therapeutics (Synergy) Limited

18 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008215926-Binding members for IgE molecules

2008215921-Delta 9 tetrahydrocannabinol derivatives